Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 10.141\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a Cc1ccc(-n2c(=S)[nH]c3nc4c(cc3c2=O)COC(C)(C)C4)cc1
b CN(C)c1ccc(/C=C2\SC(=O)N(CCc3nnc(N)s3)C2=O)cc1
Answer: a. Cc1ccc(-n2c(=S)[nH]c3nc4c(cc3c2=O)COC(C)(C)C4)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-n2c(=S)[nH]c3nc4c(cc3c2=O)COC(C)(C)C4)cc1
Cc1ccc(-n2c(=S)[nH]c3nc4c(cc3c2=O)COC(C)(C)C4)cc1
13,13-dimethyl-6-(4-methylphenyl)-5-sulfanylidene-12-oxa-2,4,6-triazatricyclo[8.4.0.03,8]tetradeca-1,3(8),9-trien-7-one